Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Rang in Aktien #26080
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Aktienkurs
$0.72978769
Marktkapitalisierung
$43.65M
Veränderung (1 Tag)
1.10%
Veränderung (1 Jahr)
-17.81%
Land
TW
Handel Bioptik Technology Incorporation (4161)

Kategorie

Aktien-Split-Historie für Bioptik Technology Incorporation (4161)
Die Aktie Bioptik Technology Incorporation (Symbol: 4161) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 20, 2026 statt.
Eine 4161-Aktie, die vor dem Aug 20, 2026 gekauft wurde, entspricht heute 0 4161-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE